ASHLEY CUPSTID: Open Payments
NPI 1760109896 · IRVING, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,378 in 228 payments from 22 companies in 2025. Trend: 2023 $4,224 · 2024 $3,012 · 2025 $5,378
Food & beverage: $5,142Education: $235
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 18 | $810 |
| Galderma Laboratories, L.P. | 35 | $735 |
| GENZYME CORPORATION | 16 | $589 |
| ABBVIE INC. | 35 | $582 |
| Arcutis Biotherapeutics, Inc. | 22 | $324 |
| Janssen Biotech, Inc. | 6 | $283 |
| Organon LLC | 10 | $280 |
| Amgen Inc. | 9 | $277 |
| Botanix SB Inc | 16 | $255 |
| Lilly USA, LLC | 8 | $247 |
Products named: DUPIXENT, NEMLUVIO, SKYRIZI, Zoryve, TREMFYA, SOFDRA, VTAMA, Bimzelx.
Industry payments across TX — which companies pay providers there.
